Back
iShares MSCI ACWI Low Carbon Target ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
61
CRBN
iShares MSCI ACWI Low Carbon Target ETF
Last Price:
195.25
Seasonality Move:
2.78%
Sell
31
VKTX
Viking Therapeutics
Last Price:
49.61
Seasonality Move:
48.88%
Buy
61
iShares MSCI ACWI Low Carbon Target ETF (CRBN)
is a Buy
Is iShares MSCI ACWI Low Carbon Target ETF a Buy, Sell or Hold?
- The current iShares MSCI ACWI Low Carbon Target ETF [CRBN] share price is $195.44. The Score for CRBN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CRBN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $49.58. The Score for VKTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBN Stock Price Chart
What is iShares MSCI ACWI Low Carbon Target ETF's stock price today?
-
The iShares MSCI ACWI Low Carbon Target ETF share price today is $195.44
The current trend is moderately bearish and CRBN is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $49.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
CRBN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 47.14 | Sell |
| Chaikin Money Flow: | -2866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (194.57 - 198.53) | Sell |
| Bollinger Bands (100): | (184.64 - 196.1) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.73 | Sell |
| Relative Strength Index (14 RSI): | 31.07 | Sell |
| Chaikin Money Flow: | -5700963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.14 - 72.42) | Sell |
| Bollinger Bands (100): | (54.02 - 67.2) | Sell |
CRBN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 198.44 | Sell |
| 20-day SMA: | 196.43 | Sell |
| 50-day SMA: | 194.84 | Buy |
| 200-day SMA: | 183.76 | Buy |
| 8-day EMA: | 197.3 | Sell |
| 20-day EMA: | 196.71 | Sell |
| 50-day EMA: | 194.53 | Buy |
| 200-day EMA: | 183.73 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.63 | Sell |
| 20-day SMA: | 65.79 | Sell |
| 50-day SMA: | 64.39 | Sell |
| 200-day SMA: | 61.54 | Sell |
| 8-day EMA: | 58.56 | Sell |
| 20-day EMA: | 63.04 | Sell |
| 50-day EMA: | 63.68 | Sell |
| 200-day EMA: | 55.81 | Sell |
iShares MSCI ACWI Low Carbon Target ETF Earnings Growth & CRBN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
iShares MSCI ACWI Low Carbon Target ETF Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||